De novo cutaneous neoplasm: biologic behavior in an immunosuppressed patient

Plastic and Reconstructive Surgery
M E Beatty, M B Habal

Abstract

The treatment of cutaneous squamous cell carcinoma in patients who are immunosuppressed should include early and adequate excision and extremely close follow-up. If the patients' tumor is aggressive, treatment should be aggressive even with discontinuation of the immunosuppression, which may lead to the death of the allograft. Sacrifice of the allograft in such an instance will lead to survival of the patient. In our patient, the continuous survival of the allograft with good renal function, in spite of the discontinuation of the immunosuppressive agents, can be interpreted only on the basis of graft adaptation.

Citations

Sep 1, 1994·Transplantation Science·A G Sheil
Apr 1, 1992·Oral Surgery, Oral Medicine, and Oral Pathology·E RegevJ Lustmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
John S HammesAmit Sharma
© 2021 Meta ULC. All rights reserved